The researchers noted that multiple studies have documented substantial declines in cancer incidence across multiple types of ...

ImPact Biotech shared interim results at the American Society of Clinical Oncology 2024 in June in which 10 of the 13 (77%) response-evaluable patients achieved a CR at the end of ITP. The company is ...

The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) ...

A new study released to coincide with World Cancer Research Day today argues that wider access to clinical trials of new ...

Researchers sought to assess the reporting of patient-reported outcomes in associated clinical trial publications.

The university said these accolades were a testament to Dr Lee’s dedication to advancing oncology research and improving ...

Dr. Chirag Jani, a Phoebe Cancer Center hematologist and oncologist beloved by his patients and well-respected by his peers, has been named president of the Georgia Society of Clinical Oncology. Jani ...

UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation ...

Suresh S. Ramalingam, MD, FACP, FASCO, discusses the background and next steps of the LAURA study which evaluated osimertinib ...

Highlights include new safety and efficacy data of Barrigel™rectal spacer, the first and only sculptable rectal spacer1-3• Teleflex to host ...

At ESMO Congress 2024, Shuji Ogino, MD, PhD, MS, explained that the rising incidence of young-onset cancer may be due to ...

An oncologist diagnoses and treats cancer. With an oncologist referral, you go to a specialty center for further evaluation.